Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen or nifedipine for postictal symptoms in epilepsy
NCT03949478Phase 2Recruiting
- Sponsor
- University of Calgary
- Start
- Feb 2021
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofen, nifedipine GITS in epilepsy, sponsored by University of Calgary. Started Feb 2021; status: recruiting.
02
Drugs
ibuprofennifedipine GITS
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03949478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03949478.